HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

oxamflatin

structure given in first source
Also Known As:
(2E)-5-(3-(phenylsulfonylamino)phenyl)pent-2-ene-4-ynohydroxamic acid
Networked: 8 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Dear, Anthony E: 2 articles (05/2008 - 07/2004)
2. Whitecross, Kate F: 1 article (05/2008)
3. Cluse, Leonie A: 1 article (05/2008)
4. Newbold, Andrea: 1 article (05/2008)
5. Johnstone, Ricky W: 1 article (05/2008)
6. Lindemann, Ralph K: 1 article (05/2008)
7. Jiang, Shi-Wen: 1 article (05/2007)
8. Podratz, Karl C: 1 article (05/2007)
9. Dowdy, Sean C: 1 article (05/2007)
10. Meng, Xue W: 1 article (05/2007)

Related Diseases

1. Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
2. Fibrosarcoma
3. Renal Cell Carcinoma (Grawitz Tumor)
4. Neoplasms (Cancer)
5. Endometrial Neoplasms (Endometrial Cancer)

Related Drugs and Biologics

1. Urokinase-Type Plasminogen Activator (Urokinase)
2. Histone Deacetylase Inhibitors
3. Sodium
4. Butyrates (Butyrate)
5. N- (2- aminophenyl)- 4- (N- (pyridin- 3- ylmethoxycarbonyl)aminomethyl)benzamide (MS 275)
6. trichostatin A (A 300)
7. TNF-Related Apoptosis-Inducing Ligand
8. scriptaid
9. vorinostat (suberoylanilide hydroxamic acid)
10. Cyclooxygenase 2 (Cyclooxygenase-2)